Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

From Agadez to Zinder: estimating coverage of the MenAfriVac™ conjugate vaccine against meningococcal serogroup A in Niger, September 2010 - January 2012.

Caini S, Beck NS, Yacouba H, Maiga I, Chaibou I, Hinsa I, Adakal A, Issoufou A, Kim SH, Pezzoli L.

Vaccine. 2013 Mar 15;31(12):1597-603. doi: 10.1016/j.vaccine.2013.01.015. Epub 2013 Jan 19.

PMID:
23337027
2.

Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.

Djingarey MH, Barry R, Bonkoungou M, Tiendrebeogo S, Sebgo R, Kandolo D, Lingani C, Preziosi MP, Zuber PL, Perea W, Hugonnet S, Dellepiane de Rey Tolve N, Tevi-Benissan C, Clark TA, Mayer LW, Novak R, Messonier NE, Berlier M, Toboe D, Nshimirimana D, Mihigo R, Aguado T, Diomandé F, Kristiansen PA, Caugant DA, Laforce FM.

Vaccine. 2012 May 30;30 Suppl 2:B40-5. doi: 10.1016/j.vaccine.2011.12.073. Review.

PMID:
22607898
3.

Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.

Patel M, Lee CK.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001093. Review.

PMID:
15674874
4.

[Meningococcal disease in the Netherlands: media hype, but not an epidemic].

van Furth AM, Zaaijer HL.

Ned Tijdschr Geneeskd. 2001 Sep 8;145(36):1716-8. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd 2001 Sep 22;145(38):1872.

PMID:
11572168
5.

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.

Okoko BJ, Idoko OT, Adegbola RA.

Vaccine. 2009 Mar 23;27(14):2023-9. doi: 10.1016/j.vaccine.2008.11.092. Epub 2008 Dec 16. Review.

PMID:
19095025
6.

Neisseria meningitidis B vaccines.

Panatto D, Amicizia D, Lai PL, Gasparini R.

Expert Rev Vaccines. 2011 Sep;10(9):1337-51. doi: 10.1586/erv.11.103. Review.

PMID:
21919622
7.

Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014.

Djingarey MH, Diomandé FV, Barry R, Kandolo D, Shirehwa F, Lingani C, Novak RT, Tevi-Benissan C, Perea W, Preziosi MP, LaForce FM.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S434-41. doi: 10.1093/cid/civ551. Review.

8.

Challenges for development of meningococcal vaccines in infants and children.

Deasy A, Read RC.

Expert Rev Vaccines. 2011 Mar;10(3):335-43. doi: 10.1586/erv.11.3. Review.

PMID:
21434801
9.

MeNZB vaccine and epidemic control: when do you stop vaccinating?

Loring BJ, Turner N, Petousis-Harris H.

Vaccine. 2008 Nov 5;26(47):5899-904. doi: 10.1016/j.vaccine.2008.08.062. Epub 2008 Sep 17. Review.

PMID:
18804134
10.

Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaign.

Chiappini E, Venturini E, Bonsignori F, Galli L, de Martino M.

Acta Paediatr. 2010 Nov;99(11):1609-14. doi: 10.1111/j.1651-2227.2010.01908.x. Epub 2010 Jun 25. Review.

PMID:
20545931
11.

Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.

Poland GA.

Clin Infect Dis. 2010 Mar 1;50 Suppl 2:S45-53. doi: 10.1086/648964. Review.

PMID:
20144016
12.

Neisseria meningitidis serogroup A vaccines: an overview.

Vergnano S, Heath P.

Expert Rev Vaccines. 2003 Aug;2(4):571-82. Review.

PMID:
14711341
13.

A critical appraisal of the recommendations for the use of meningococcal conjugate vaccines.

Sáfadi MA, Berezin EN, Oselka GW.

J Pediatr (Rio J). 2012 May;88(3):195-202. doi: doi:10.2223/JPED.2167. Epub 2012 May 23. Review.

14.

MenACWY-TT vaccine for active immunization against invasive meningococcal disease.

Papaevangelou V, Spyridis N.

Expert Rev Vaccines. 2012 May;11(5):523-37. doi: 10.1586/erv.12.32. Review.

PMID:
22827239
15.

Optimizing protection against meningococcal disease.

Reisinger KS, Black S, Stoddard JJ.

Clin Pediatr (Phila). 2010 Jun;49(6):586-97. doi: 10.1177/0009922809354327. Epub 2010 Jan 20. Review.

PMID:
20089551
16.

Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature.

Miles M, Ryman TK, Dietz V, Zell E, Luman ET.

Vaccine. 2013 Mar 15;31(12):1560-8. doi: 10.1016/j.vaccine.2012.10.089. Epub 2012 Nov 26. Review.

PMID:
23196207
17.

Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys.

MacNeil A, Lee CW, Dietz V.

Vaccine. 2014 Sep 3;32(39):4893-900. doi: 10.1016/j.vaccine.2014.07.005. Epub 2014 Jul 18. Review.

PMID:
25045821

Supplemental Content

Support Center